Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Trisedil
1. 749-13-3
2. Triperidol
3. Trisedil
4. Psychoperidol
5. Flumoperone
6. Psicoperidol
7. Trisedyl
8. Psicoperidol-r
9. Mcn-jr-2498
10. Trifluperidolo
11. R-2498
12. Nsc 170978
13. P 459
14. 1-(4-fluorophenyl)-4-[4-hydroxy-4-[3-(trifluoromethyl)phenyl]piperidin-1-yl]butan-1-one
15. Nsc-170978
16. Chembl15023
17. 1-butanone, 1-(4-fluorophenyl)-4-(4-hydroxy-4-(3-(trifluoromethyl)phenyl)-1-piperidinyl)-
18. R8869q7r8i
19. Nsc170978
20. Triperidol (tn)
21. 4-fluoro-4,4-idrossi-4-(m-trifluorometil-fenil)-piperidino-butirrofenone
22. Trifluperidolum
23. Trifluperidolo [dcit]
24. Trifluperidolo [italian]
25. 1-(4-fluorophenyl)-4-(4-hydroxy-4-(3-(trifluoromethyl)phenyl)piperidin-1-yl)butan-1-one
26. 1-butanone, 1-(4-fluorophenyl)-4-[4-hydroxy-4-[3-(trifluoromethyl)phenyl]-1-piperidinyl]-
27. Trifluperidolum [inn-latin]
28. Butyrophenone, 4'-fluoro-4-(4-hydroxy-4-(.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)piperidino)-
29. Butyrophenone, 4'-fluoro-4-[4-hydroxy-4-(.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)piperidino]-
30. Trifluperidol [usan:inn:ban]
31. Brn 1556208
32. Unii-r8869q7r8i
33. .psi.coperidol
34. 1-(4-fluorophenyl)-4-{4-hydroxy-4-[3-(trifluoromethyl)phenyl]piperidin-1-yl}butan-1-one
35. .psi.coperidol-r
36. 4'-fluoro-4-(4-hydroxy-4-(.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)piperidino)butyrophenone
37. 4'-fluoro-4-[4-hydroxy-4-(.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)piperidino]butyrophenone
38. Lopac-t-103
39. Trifluperidol [mi]
40. Trifluperidol [inn]
41. Trifluperidol (usan/inn)
42. 4'-fluoro-4-(4-hydroxy-4-(alpha,alpha,alpha-trifluoro-m-tolyl)piperidino)butyrophenone
43. 4-fluoro-4,4-idrossi-4-(m-trifluorometil-fenil)-piperidino-butirrofenone [italian]
44. Trifluperidol [usan]
45. Lopac0_001243
46. 5-21-02-00406 (beilstein Handbook Reference)
47. Schembl120862
48. Trifluperidol [mart.]
49. Trifluperidol [who-dd]
50. Dtxsid4023703
51. Chebi:135662
52. Hms2090p16
53. Bcp28492
54. Bdbm50047016
55. Ccg-205317
56. Db13552
57. Sdccgsbi-0051210.p002
58. Butyrophenone, 4'-fluoro-4-(4-hydroxy-4-(alpha,alpha,alpha-trifluoro-m-tolyl)piperidino)-
59. Ncgc00015983-01
60. Ncgc00015983-02
61. Ncgc00015983-03
62. Ncgc00015983-06
63. Ncgc00162376-01
64. Wln: T6ntj A3vr Df& Dq Dr Cxfff
65. 1st161655
66. Ns00010654
67. D02625
68. Ab00918346-05
69. L001285
70. Q4463264
71. Brd-k43605761-003-05-4
72. R-2498; R 2498; R2498
73. Butyrophenone,.alpha.,.alpha.-trifluoro-m-tolyl)piperidino]-
74. 1-(4-fluoro-phenyl)-4-[4-hydroxy-4-(3-trifluoromethyl-phenyl)-piperidin-1-yl]-butan-1-one
75. 1-(4-fluorophenyl)-4-(4-hydroxy-4-(3-(trifluoromethyl)phenyl)-1-piperidinyl)-1-butanone
76. 1-(4-fluorophenyl)-4-(4-hydroxy-4-[3-(trifluoromethyl)phenyl]-1-piperidinyl)-1-butanone #
77. 1-(4-fluorophenyl)-4-[4-hydroxy-4-[3-(trifluoromethyl)phenyl]-1-piperidyl]-butan-1-one
78. 1-(4-fluorophenyl)-4-[4-hydroxy-4-[3-(trifluoromethyl)phenyl]-1-piperidyl]butan-1-one
79. 4'-fluoro-4-[4-hydroxy-4-(.alpha.,.alpha.-trifluoro-m-tolyl)piperidino]butyrophenone
80. 1-(4-fluoro-phenyl)-4-[4-hydroxy-4-(3-trifluoromethyl-phenyl)-piperidin-1-yl]-butan-1-one (trifluperidol)
81. 1-butanone, 1-(4-fluorophenyl)-4-[4-hydroxy-4-[3-(trifluoromethyl)phenyl]-1-pi Peridinyl]-
| Molecular Weight | 409.4 g/mol |
|---|---|
| Molecular Formula | C22H23F4NO2 |
| XLogP3 | 3.5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 6 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 40.5 |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 537 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)
Dopamine Antagonists
Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)
N - Nervous system
N05 - Psycholeptics
N05A - Antipsychotics
N05AD - Butyrophenone derivatives
N05AD02 - Trifluperidol
ABOUT THIS PAGE
32
PharmaCompass offers a list of Trifluperidol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Trifluperidol manufacturer or Trifluperidol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Trifluperidol manufacturer or Trifluperidol supplier.
PharmaCompass also assists you with knowing the Trifluperidol API Price utilized in the formulation of products. Trifluperidol API Price is not always fixed or binding as the Trifluperidol Price is obtained through a variety of data sources. The Trifluperidol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Trifluperidol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trifluperidol, including repackagers and relabelers. The FDA regulates Trifluperidol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trifluperidol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Trifluperidol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Trifluperidol supplier is an individual or a company that provides Trifluperidol active pharmaceutical ingredient (API) or Trifluperidol finished formulations upon request. The Trifluperidol suppliers may include Trifluperidol API manufacturers, exporters, distributors and traders.
click here to find a list of Trifluperidol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Trifluperidol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Trifluperidol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Trifluperidol GMP manufacturer or Trifluperidol GMP API supplier for your needs.
A Trifluperidol CoA (Certificate of Analysis) is a formal document that attests to Trifluperidol's compliance with Trifluperidol specifications and serves as a tool for batch-level quality control.
Trifluperidol CoA mostly includes findings from lab analyses of a specific batch. For each Trifluperidol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Trifluperidol may be tested according to a variety of international standards, such as European Pharmacopoeia (Trifluperidol EP), Trifluperidol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Trifluperidol USP).
